Merck is hosting two live webinars on Oct 8th and 28th focused on an option for the prevention of RSV lower respiratory tract disease in neonates and infants. These educational sessions are designed for U.S. healthcare professionals and healthcare business professionals. Each event is a non-CME program and presents information consistent with FDA guidelines.
📅 Choose Your Date & Register
Wednesday, October 8, 2025 | 12:15 PM ET
Speaker: Joseph B. Domachowske, MD
Professor of Pediatrics and Microbiology & Immunology
Division of Pediatric Infectious Diseases, SUNY Upstate Medical University
Dr. Domachowske will share his expertise in pediatric infectious diseases, focusing on RSV and prevention strategies for neonates and infants.
Tuesday, October 28, 2025 | 12:15 PM ET
Speaker: Debra Lynne Carter, MD, CPE, FAAP
Senior Medical Director, Quality, Lehigh Valley Physician Group
Executive Vice Chair, Department of Pediatrics, Lehigh Valley Reilly Children’s Hospital
Dr. Carter will offer insights from her clinical and leadership experience in pediatric care, with a focus on RSV prevention in vulnerable populations.
How CPP Can Help
As a national vaccine buying group, CPP partners with leading manufacturers to offer discounted pricing on a full portfolio of pediatric and adult vaccines including RSV prevention options like Merck’s Enflonsia™. This monoclonal antibody is designed to protect infants under 8 months during their first RSV season and is now part of the CPP portfolio.
CPP members benefit from:
- Exclusive discounts through the CPP/Merck contract
- Billing support and coding guidance for RSV immunizations
- Resources to streamline vaccine management and improve patient care
If you would like to enroll with the CPP/Merck discount or need updated pricing, please contact the CPP office at cpp@nationwidechildrens.org. Not a member? Reach out to our team to learn how CPP can support and enhance your practice’s immunization program.